Molecular Breast Imaging (MBI)

Molecular Breast Imaging (MBI) is a nuclear medicine imaging technique used to detect and diagnose breast cancer. It involves the use of a small amount of radioactive tracer, which is injected into the body and accumulates in cancer cells, allowing for their detection using a specialized camera.

Procedure

The MBI procedure typically involves the following steps:

• A small amount of radioactive tracer, usually Technetium-99m (Tc-99m) sestamibi, is injected into a vein in the arm.
• The patient then waits for approximately 5-10 minutes to allow the tracer to accumulate in the breast tissue.
• The patient lies on their back or sits upright, and a specialized camera, called a gamma camera, is positioned over the breast.
• The gamma camera detects the radiation emitted by the tracer and creates images of the breast tissue.
• Multiple images are taken from different angles to provide a comprehensive view of the breast.

Principle

MBI is based on the principle that cancer cells have increased metabolic activity compared to normal cells. The radioactive tracer used in MBI accumulates in areas with high metabolic activity, such as cancer cells, allowing for their detection.

Advantages

MBI has several advantages over other breast imaging modalities:

• High sensitivity and specificity for detecting breast cancer, particularly in dense breast tissue.
• Able to detect cancers that may not be visible on mammography or ultrasound.
• Less affected by breast density compared to mammography.
• Can be used to monitor treatment response and detect recurrence.

Limitations

MBI also has some limitations:

• Radiation exposure, although relatively low.
• May not provide detailed anatomical information compared to other imaging modalities.
• Not suitable for patients with certain medical conditions, such as pregnancy or breastfeeding.

Indications

MBI is typically used in the following situations:

• High-risk breast cancer screening.
• Evaluation of suspicious breast lesions.
• Monitoring of breast cancer treatment response and detection of recurrence.
• Problem-solving in cases where other imaging modalities are inconclusive.

Conclusion

Molecular Breast Imaging is a valuable tool in the diagnosis and management of breast cancer. Its high sensitivity and specificity make it an attractive option for detecting breast cancer, particularly in dense breast tissue. However, it should be used in conjunction with other imaging modalities and clinical evaluation to provide comprehensive patient care.

Frequently Asked Questions (FAQs)

What is Molecular Breast Imaging (MBI)?
A diagnostic imaging technique that uses a small amount of radioactive tracer to detect breast cancer.

How does MBI work?
It uses gamma cameras to detect the uptake of a radioactive tracer in breast tissue.

Is MBI used for screening or diagnosis?
Primarily used for diagnostic purposes, especially in dense breast tissue.

What is the radioactive tracer used in MBI?
Technetium-99m sestamibi.

Are there any risks associated with MBI?
Exposure to small amounts of radiation.

How long does an MBI procedure take?
Approximately 30-60 minutes.

Is MBI painful?
No, it is a non-invasive and painless procedure.

Can MBI detect cancer in dense breast tissue?
Yes, it can help detect cancer in dense breast tissue where mammography may be less effective.

Is MBI covered by insurance?
Coverage varies depending on the insurance provider and individual policy.

How is MBI different from a mammogram?
MBI uses a radioactive tracer to detect cancer, while mammograms use X-rays.